跳至主要内容
临床试验/CTRI/2022/01/039544
CTRI/2022/01/039544已完成2 期

Therapeutic Evaluation of the Efficacy of a Polyherbal Unani Formulation in the form of Habb (Pill) in the Management of Niqris Muzmin (Chronic Gout-Hyperuricemia).

Central Council for Research in Unani Medicine New Delhi0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Clinically/Radiologically diagnosed patients of Chronic Gout with Sr. Uric Acid Level > 7.2 mg/dL.
  • 1. Patients with Joint Pain.
  • 2. Patients with morning stiffness > 30 minutes.
  • 3. Patients with joint swelling of the affected joint(s).
  • 4. Patients with muscular weakness of the joint(s).
  • 5. Patients with restricted movement of the joint(s).

排除标准

  • 1. Any other disease or syndrome except Niqris.
  • 2. Pregnant and Lactating women.

研究者

发起方
Central Council for Research in Unani Medicine New Delhi

相似试验

A Clinical Study on a Polyherbal Unani Formulation... | 临床试验